Litcius/Paper detail

Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial

Fabio Efficace, François‐Xavier Mahon, Johan Richter, Alfonso Piciocchi, Marta Cipriani, Franck E. Nicolini, Jiřı́ Mayer, Daniela Žáčková, Jeroen J. W. M. Janssen, Panayiotis Panayiotidis, Hanne Vestergaard, Perttu Koskenvesa, António Almeida, Henrik Hjorth‐Hansen, Joaquín Martínez‐López, Ulla Olsson‐Strömberg, Andreas Hochhaus, Marc Berger, Gabriel Étienne, Hana Klamová, Edgar Faber, Philippe Rousselot, Markus Pfirrmann, Susanne Saußele

2024Leukemia11 citationsDOIOpen Access PDF

Topics & Concepts

DiscontinuationMedicineQuality of life (healthcare)Myeloid leukemiaInternal medicinePediatricsNursingChronic Myeloid Leukemia TreatmentsEosinophilic Disorders and SyndromesChronic Lymphocytic Leukemia Research
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial | Litcius